MERSILENE TAPE UNKNOWN PRODUCT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2018-11-20 for MERSILENE TAPE UNKNOWN PRODUCT manufactured by Ethicon Inc..

Event Text Entries

[128030335] (b)(4). This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided. Citation: obstet gynecol 2007;109:493? 4 - (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[128030336] It was reported via journal article: "title : vesicovaginal fistula formation after cervical cerclage mimicking premature rupture of membranes". Author : l. Lewis wall, md, dphil, fareesa khan, md, and stephanie adams, citation: obstet gynecol 2007;109:493? 4. This case report aimed to present a (b)(6)-year-old female patient who underwent placement of a mcdonald cervical cerclage using mersilene tape under spinal anesthesia for cervical insufficiency. Two weeks later patient began noticing intermittent episodes of vaginal wetness, but no indication of ruptured membrane and amniotic fluid volumes were normal at ultrasound examination. She was given oral indomethacin and subcutaneous terbutaline for recurrent preterm labor. A vesicovaginal fistula was diagnosed by filling the bladder with 300ml sterile water with 20ml methylene blue dye, and copious spillage of blue dye into the vagina occurred immediately after instillation. At cystoscopy, the mersilene tape was clearly visible in the posterior bladder just above the interureteric ridge. The cerclage was removed during caesarian delivery. After delivery, transurethral foley catheter was placed to allow spontaneous healing of the fistula, but it failed. She underwent transvaginal repair of vesicovaginal fistula 10 weeks after delivery. The fistula healed completely without further complications. Nine months after fistula repair, she had normal bladder function with no incontinence and no voiding dysfunction. The authors believed that the bladder was not penetrated directly during cerclage placement; rather, the mersilene tape was probably placed extremely close to the bladder and subsequently eroded through the urothelium over the course of the next few weeks. This process led to intermittent urine loss until the fistula became so large that the patient experienced continuous urinary leakage. The use of the shirodkar or a similar technique in which the bladder is mobilized off the cervix before suture placement may reduce the incidence of such injuries.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2210968-2018-77259
MDR Report Key8091225
Report SourceLITERATURE
Date Received2018-11-20
Date of Report2018-11-12
Date Mfgr Received2018-11-12
Date Added to Maude2018-11-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDARLENE KYLE
Manufacturer StreetP.O. BOX 151, ROUTE 22 WEST
Manufacturer CitySOMERVILLE NJ 088760151
Manufacturer CountryUS
Manufacturer Postal088760151
Manufacturer Phone9082182792
Manufacturer G1ETHICON INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMERSILENE TAPE UNKNOWN PRODUCT
Generic NameINSTRUMENT, SURGICAL, DISPOSABLE
Product CodeKDC
Date Received2018-11-20
Catalog NumberUNK
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerETHICON INC.
Manufacturer AddressP.O. BOX 151, ROUTE 22 WEST SOMERVILLE NJ 088760151 US 088760151


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-11-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.